Mental Health DailyResearch. Evidence. Perspective.Published research on cannabidiol.
A 2026 Phase I crossover trial found that a 400-mg powdered cannabidiol formulation reached peak CBD faster than Epidyolex oil in healthy adults — 3 h vs. 3.5 h when fasted and 5 h vs. 8 h a…
Read articleCBD has solid evidence for rare pediatric epilepsies, preliminary signal in anxiety and psychosis, and insufficient evidence for most conditions it’s marketed for.
Read articleThe relationship between cannabis use (CU) and anxiety disorders (AD) is a topic of ongoing debate and research within the scientific community. While some studies suggest cannabis can have …
Read articleCannabidiol (CBD), a compound found in Cannabis sativa, has emerged as a substance of interest in the medical community due to its potential therapeutic benefits for various neurological and…
Read articleRecent research has shed light on the potential benefits of cannabis-based medicinal products (CBMPs) in treating Generalized Anxiety Disorder (GAD), especially in patients with sleep distur…
Read articleEpilepsy affects over 50 million people worldwide, making it one of the most common neurological disorders globally. For many living with epilepsy, achieving reliable seizure control remains…
Read articleCBD (Cannabidiol) is a phytocannabinoid with medicinal properties derived from the cannabis plant (i.e. marijuana). Of all ~113 active phytocannabinoids, or plant-based chemical constituents…
Read article
